51results about How to "Treatment effect" patented technology

The present invention provides a process, which allows working with viscous petroleum referred to as “heavy and extra heavy crudes” by adding an appropriate biosurfactant to an aqueous phase containing a biosurfactant active compound. The result is the formation of a stable crude / water emulsion even with salt present therein.

The use of extract form Wangla (coeloglossum viride (L) Hartm. Var. Bracteatum (Willd.) Richter), succinate derivative esters, and a derivative and pharmaceutical acceptable salts thereof, for the manufacture of a pharmaceutical preparation for the treatment of dementia, particularly for the treatment of Alzheimer' disease and Vascular dementia. Through Animal experiment, it has been demonstrated that, succinate derivative esters can improve learning and memory ability in dementia rats induced by scopolamine and cyclohexenyl imine; improve learning and memory ability in dementia rats induced by β-amyloid; improve learning and memory ability in dementia rats induced by permanent ligation of bilateral carotid; and improve memory ability of normal animals. It has the advantage of high activity, low toxicity and no inhibition to cholinesterase.

A veterinary injection of berberine sulfate for treating the infectious dycentery, diarrhea and fever of pig is prepared through heating water to 40-80 deg.C, proportionally adding berberine sulfate, stirring while dissolving, adding activated carbon, stirring, laying aside, dissolving the glucose for injection in water at 30-70 deg.C, mixing it with said solution, and adding the water for injection proportionally.

Disclosed is a composition for use in the prevention of a hypoglycemic condition, which comprises at least one compound selected from a branched amino acid, a pharmaceutically acceptable salt thereof and a derivative of the amino acid or salt as an active ingredient. The composition can promote the uptake of a saccharide into a brain cell to thereby prevent a hypoglycemic condition.

The present invention relates to novel antiobesity and hypocholesterolemic compounds, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. More particularly, the present invention relates to novel β-aryl-α-oxysubstituted alkylcarboxylic acids of the general formula (I),their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. The present invention also relates to a process for the preparation of the above said novel compounds, their analogs, their derivatives, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them. The present invention also relates to novel intermediates, processes for their preparation and their use in the preparation of compounds of formula (I).

The use of extract form Wangla (coeloglossum viride (L) Hartm. Var. Bracteatum (Willd.) Richter), succinate derivative esters, and a derivative and pharmaceutical acceptable salts thereof, for the manufacture of a pharmaceutical preparation for the treatment of dementia, particularly for the treatment of Alzheimer' disease and Vascular dementia. Through Animal experiment, it has been demonstrated that, succinate derivative esters can improve learning and memory ability in dementia rats induced by scopolamine and cyclohexenyl imine; improve learning and memory ability in dementia rats induced by β-amyloid; improve learning and memory ability in dementia rats induced by permanent ligation of bilateral carotid; and improve memory ability of normal animals. It has the advantage of high activity, low toxicity and no inhibition to cholinesterase.

Disclosed are a compound of formula I, stereoisomers, pharmaceutically acceptable salts or hydrates thereof, a pharmaceutical composition comprising the same, a process for preparing the same and use thereof. The compound may also be used to prepare a medicament to treat viral infections, especially to prepare a medicament to treat hepatitis B virus and human immunodeficiency virus with little toxic side effects.

The invention relates to the field of medical instruments, in particular to a medical device for a trauma operation of the general surgery department. The device comprises a bed board, a second bearing and a third bearing, wherein four sets of supporting legs are symmetrically arranged at four corners of the bottom end of the bed board; supports are fixedly connected to the bottom ends of the supporting legs; two sets of T-shaped sliding grooves are symmetrically formed in the front side and the rear side of the bed board; T-shaped sliding blocks are slidably connected into the T-shaped sliding grooves; six sets of binding belt fixing assemblies are fixedly connected to the outer side ends of the T-shaped sliding blocks; first fixing binding belts are fixedly connected to the binding beltfixing assemblies on the left side and the right side, a four-limb fixing binding belt is fixedly connected to each of the front side and the rear side of the bottom end of each first fixing binding belt, a second fixing binding belt is fixedly connected to the binding belt fixing assembly in the middle portion, and a waist fixing binding belt is fixedly connected to the middle of the bottom end of the second fixing binding belt. The medical device for the trauma operation of the general surgery department provided by the invention can well fix limbs of a patient and can open a wound of the patient.

The present invention encompasses methods and compositions for generating a biomimetic proteoglycan. The invention includes methods of treating a disease, disorder, or condition of soft tissue using a biomimetic proteoglycan.

The invention relates to a method adopting a compound traditional Chinese medicine to treat uterine fibroid and uterine cancer. The method is characterized in that four prescriptions are combined and taken; a prescription 1 is prepared by adding water to seven fresh earthworms with the weight of 3-5g and boiling, and then is directly taken; a prescription 2 is prepared by taking 3-5 fresh Radix Asparagis every time and steaming, and is taken, or the prescription 2 is a Radix Asparagi capsule; a prescription 3 is prepared by taking 15-20g of Blaps rynchopetera Fairmaire, 15-20g of pine mushroom, 15-20g of Jiapi, 15-20g of porcupine quill, 15-20g of Radix Notoginseng, 8-12g of Rhizoma Paridis, 8-12g of centipede, 8-12g of scorpion, 8-12g of gecko, 3-6g of Spanish fly and 15-20g of fly maggot, and grinding to form powder, and is taken; and a prescription 4 is prepared by taking 15-20g of Goldhair Hedyotis Herb, 12-20g of Scutellaria barbata, 15-20g of Japanese Peristrophe Herb, 15-20g of Himalaya Nightshade, 15-20g of honeysuckle flower, 15-20g of Herba Plantaginis and 15-20g of Adiantum capillus-veneris L., adding water and decocting to obtain a soup, and the soup is taken. The treatment effect of the method is good.